Dacetuzumab plus rituximab, ifosfamide, carboplatin and...

  • Main
  • 2015 / 02
  • Dacetuzumab plus rituximab, ifosfamide, carboplatin and...

Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placebo-controlled phase 2b trial

Fayad, Luis, Ansell, Stephen M., Advani, Ranjana, Coiffier, Bertrand, Stuart, Robert, Bartlett, Nancy L., Forero-Torres, Andres, Kuliczkowski, Kazimierz, Belada, David, Ng, Edmund, Drachman, Jonathan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2015.1007504
Date:
February, 2015
File:
PDF, 1.83 MB
english, 2015
Conversion to is in progress
Conversion to is failed